B
Bioretec Oy
OMXH:BRETEC
Bioretec Oy
OMXH:BRETEC
Price:
0.0226
EUR
Market Closed
Market Cap:
€34.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Bioretec Oy
OMXH:BRETEC
|
FI |
|
DXC Technology Co
NYSE:DXC
|
US |
|
Triputra Agro Persada Tbk PT
IDX:TAPG
|
ID |
|
Nano-X Imaging Ltd
NASDAQ:NNOX
|
IL |
|
Atea Pharmaceuticals Inc
NASDAQ:AVIR
|
US |
|
A
|
Aeon Thana Sinsap Thailand PCL
SET:AEONTS
|
TH |
|
P
|
Pennant Group Inc
NASDAQ:PNTG
|
US |
|
Sturm Ruger & Company Inc
NYSE:RGR
|
US |
|
Heidelberg Pharma AG
XETRA:HPHA
|
DE |
|
TPG RE Finance Trust Inc
NYSE:TRTX
|
US |
Wall St Price Targets
BRETEC Price Targets Summary
Bioretec Oy
Bioretec Oy
Wall Street analysts forecast BRETEC stock price to drop over the next 12 months.
According to Wall Street analysts, the average 1-year price target for BRETEC is 0.0184 EUR with a low forecast of 0.0182 EUR and a high forecast of 0.0189 EUR.
Lowest Forecast
Price Target
0.0182
EUR
20% Downside
Average Forecast
Price Target
0.0184
EUR
19% Downside
Highest Forecast
Price Target
0.0189
EUR
16% Downside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BRETEC's stock price target?
Price Target
0.0184
EUR
0.0184
EUR
According to Wall Street analysts, the average 1-year price target for BRETEC is 0.0184 EUR with a low forecast of 0.0182 EUR and a high forecast of 0.0189 EUR.
What is the Revenue forecast for Bioretec Oy?
Projected CAGR
52%
52%
Over the last 6 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 52%.
